Daiichi Sankyo’s Deal With Ranbaxy Hits A Snag

MUMBAI - There is trouble for Japanese drug maker Daiichi Sankyo's takeover proposal of India's largest pharmaceutical company Ranbaxy as India's stock market regulator, the Securities and Exchange Board of India, has rejected a plea from Ranbaxy promoters to execute the 34.8 percent stake sale to Daiichi Sankyo through live-market transactions